Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Data sharing: putting Nature’s policy to the test

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 619, 698 (2023)


The reproducibility/verification analyses of published results reported in this Correspondence were funded in part by the National Institutes of Health (NIH) grants. The opinions expressed are those of the authors and not necessarily of the NIH.

Competing Interests

In the past 36 months, D.B.A. has received personal payments or promises for same from: Alkermes, Inc.; Amin Talati Wasserman for KSF Acquisition Corp (Glanbia); Clark Hill PLC; Kaleido Biosciences; Law Offices of Ronald Marron; Medpace/Gelesis; Novo Nordisk Fonden; Sports Research Corp.; and Zero Longevity Science (as stock options).


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links